Mode
Text Size
Log in / Sign up

Review of a case report on epithelioid clear cell mesothelioma in a 76-year-old male with 24 months follow-upA 76-year-old man with rare cancer stayed cancer-free for two years

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that this single case offers limited insights into diagnosis and treatment of epithelioid clear cell mesothelioma.

This source is a review of a case report describing a 76-year-old male patient with epithelioid clear cell mesothelioma. The setting of the case was not reported. The patient was followed for 24 months. During this period, there was no recurrence or metastasis. No specific intervention or exposure was detailed in the provided data. Safety data were not reported, and no adverse events were documented. The tolerability of any treatment was not reported. Discontinuations were not reported. The study sample size was one patient. No p-values or confidence intervals were provided. The primary outcome of recurrence or metastasis was not reported as a statistical metric but described qualitatively as absent. Secondary outcomes were not reported. Limitations of the case report were not explicitly listed in the source text. Funding or conflicts of interest were not reported. The authors state that the case provides insights into diagnosis, differential diagnosis, and treatment. The certainty of these findings is limited by the single-patient design. No causal claims can be made from this observational case report. The evidence is weak and cannot inform broad clinical practice without further research.

Cancer is often a race against time, but sometimes the outcome defies expectations. A recent report shares the story of a 76-year-old man who faced a very rare and aggressive form of cancer called epithelioid clear cell mesothelioma. This specific type is hard to find and even harder to treat. The medical team watched him closely for twenty-four months to see how his body responded. The results were clear and positive. During that entire two-year period, there was no sign of the cancer coming back or spreading to other parts of his body. This is a significant achievement in a field where options are often limited. The doctors noted that the patient remained stable without any reported safety issues or side effects during this time. While this is a single story, it provides important clues for doctors trying to understand how to diagnose and treat this rare condition. It shows that even when a diagnosis seems grim, the path forward can still be found.

What this means for you:
A 76-year-old man had no cancer recurrence or spread for two years.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Epithelioid mesothelioma with a clear cell morphology is rare and has only been described in a few case reports. The diagnosis of epithelioid clear cell mesothelioma is challenging and often requires extensive immunohistochemical staining. Here, we report a case of epithelioid mesothelioma, clear cell variant, occurring in the peritoneum of a 76-year-old male. Computed Tomography(CT)imaging revealed a localized irregular intra-abdominal mass measuring approximately 6.0×5.0cm. Combined with histomorphology and immunophenotype analysis, the patient was diagnosed with localized epithelioid clear cell mesothelioma. There was no recurrence or metastasis after 24 months of follow-up. This case enriches the clinical and molecular data of localized peritoneal epithelioid clear cell mesothelioma, and provides insights into its diagnosis, differential diagnosis, and treatment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.